Why invest in Fagron

Fagron is the global leader in pharmaceutical compounding, facilitating personalized treatments for patients that have specific requirements.

Why invest in Fagron

As a vertically integrated global player, Fagron is active in the entire value chain of pharmaceutical compounding. Fagron is unique in offering a full range of products and services in pharmaceutical compounding to hospitals, pharmacies and clinics and it is unique in doing so globally. Long-term secular drivers that underpin the resilience of the niche market Fagron operates in, include demographics, accessibility, personalization, and regulation. We strive to create long-term value for all our stakeholders: customers, patients, employees, investors, and society as a whole.

Revenue (in € million)

Revenue of Fagron in the past three years.

REBITDA (in € million)

REBITDA of Fagron in the past three years

Revenue per segment (in € million)

Revenue per segment in 2023.

Our geographic areas

Learn more about our areas

Key figures

Fagron ESG key figures 2023

Number of facilities
75
Units of compounded medicine supplied
18.8M
Climate change impact, scope 1 & 2 (metric tons of CO2-eq)
12,355
Employee sustainable engagement score
84%